Effect of vitamin D supplements on MS activity

Written by Ellen on February 27th, 2020December 8th, 2021.

People with MS are often advised to take high doses of vitamin D, but there’s been very little research to assess what effect this might have.

The Evidence for Oxygen awarded the 2019 Nobel prize

Written by Ellen on January 29th, 2020December 8th, 2021.

We wanted to draw attention to an interesting article published in the HBOTT Dec 2019 Newsletter.

Tysabri: reducing the risk of PML with extended interval dosing

Written by Ellen on December 12th, 2019December 8th, 2021.

Tysabri (natalizumab) is very effective for people with highly active relapsing remitting MS but it carries the risk of developing a rare but very serious brain infection called progressive multifocal […]

Sativex approved by NICE

Written by Ellen on November 20th, 2019December 8th, 2021.

Sativex, a cannabis based drug for MS related spasticity, has been approved by NICE as a cost effective treatment for the NHS in England.

Siponimod recommended for secondary progressive MS by EMA

Written by Ellen on November 20th, 2019December 8th, 2021.

The European Medicines Agency has recommended that a licence should be granted for Siponimod for the treatment of active secondary progressive MS.

Rex Robotic Exoskeleton Trial

Written by Ellen on August 29th, 2019December 8th, 2021.

East Kent leads the way in robotic trials to improve patients’ mobility.

Summer Fete Fundraiser raises over £2,000!

Written by Ellen on June 26th, 2019July 2nd, 2020.

Swanley Therapy Centre held it’s annual Summer Fete fundraiser on the 8th June 2019. The event was a great success raising over £2,000 with over 120 attendees.